'''Pentylone''' (β-Keto-Methylbenzodioxolylpentanamine, '''βk-Methyl-K''', '''βk-MBDP''', '''methylenedioxypentedrone''', or 1‐(3,4‐methylenedioxyphenyl)‐2‐(methylamino)pentan‐1‐one<ref name=pmid21960541/>) is a [[stimulant]] developed in the 1960s.<ref>Substituted phenyl-α-amino ketones. British Patent GB 1085135 (1969).</ref> It is a [[substituted cathinone]] (a type of [[substituted phenethylamine]]). It has been identified in some samples of powders sold as "NRG-1", along with varying blends of other cathinone derivatives including [[flephedrone]], [[3',4'-Methylenedioxy-α-pyrrolidinobutiophenone|MDPBP]], [[Methylenedioxypyrovalerone|MDPV]] and [[4'-Methyl-α-pyrrolidinopropiophenone|4-MePPP]].
'''Pentylone''' (<span style="word-break:break-all;">β-Keto-Methylbenzodioxolylpentanamine</span>, '''βk-Methyl-K''', '''βk-MBDP''', '''methylenedioxypentedrone''', or 1‐(3,4‐methylenedioxyphenyl)‐2‐(methylamino)pentan‐1‐one<ref name=pmid21960541/>) is a [[stimulant]] developed in the 1960s.<ref>Substituted phenyl-α-amino ketones. British Patent GB 1085135 (1969).</ref> It is a [[substituted cathinone]] (a type of [[substituted phenethylamine]]). It has been identified in some samples of powders sold as "NRG-1", along with varying blends of other cathinone derivatives including [[flephedrone]], [[3',4'-Methylenedioxy-α-pyrrolidinobutiophenone|MDPBP]], [[Methylenedioxypyrovalerone|MDPV]] and [[4'-Methyl-α-pyrrolidinopropiophenone|4-MePPP]].
It was also found in combination with 4-MePPP being sold as "NRG-3".<ref name="pmid21960541">{{cite journal |vauthors=Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J |title=Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones |journal=Drug Testing and Analysis |volume= 3|issue= 9|pages= 569–75|date=December 2010 |pmid=21960541 |doi=10.1002/dta.204 |url=}}</ref> Reports indicate side effects include feelings of paranoia, agitation and inability to sleep, with effects lasting for several days at high doses.<ref>{{cite journal |last1=Joe Bish |title=Watch Out for Pentylone, the Horrible New MDMA Additive |journal=Vice |date=Aug 4, 2017 |url=https://www.vice.com/en_uk/article/pagjxg/watch-out-for-pentylone-the-horrible-new-mdma-additive}}</ref>
It was also found in combination with 4-MePPP being sold as "NRG-3".<ref name="pmid21960541">{{cite journal |vauthors=Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J |title=Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones |journal=Drug Testing and Analysis |volume= 3|issue= 9|pages= 569–75|date=December 2010 |pmid=21960541 |doi=10.1002/dta.204 |url=}}</ref> Reports indicate side effects include feelings of paranoia, agitation and inability to sleep, with effects lasting for several days at high doses.<ref>{{cite journal |last1=Joe Bish |title=Watch Out for Pentylone, the Horrible New MDMA Additive |journal=Vice |date=Aug 4, 2017 |url=https://www.vice.com/en_uk/article/pagjxg/watch-out-for-pentylone-the-horrible-new-mdma-additive}}</ref>
Pentylone (β-Keto-Methylbenzodioxolylpentanamine, βk-Methyl-K, βk-MBDP, methylenedioxypentedrone, or 1‐(3,4‐methylenedioxyphenyl)‐2‐(methylamino)pentan‐1‐one[1]) is a stimulant developed in the 1960s.[2] It is a substituted cathinone (a type of substituted phenethylamine). It has been identified in some samples of powders sold as "NRG-1", along with varying blends of other cathinone derivatives including flephedrone, MDPBP, MDPV and 4-MePPP.
It was also found in combination with 4-MePPP being sold as "NRG-3".[1] Reports indicate side effects include feelings of paranoia, agitation and inability to sleep, with effects lasting for several days at high doses.[3]
(what is this?) (verify)
